Bristol-Myers and Celgene CEOs talk acquisition deal

9:42 AM ET Mon, 7 Jan 2019

Bristol-Myers Squibb chairman and CEO Dr. Giovanni Caforio and Celegene Chairman and CEO Mark Alles sit down with CNBC's Jim Cramer to discuss their recently announced acquisition deal.